---
title: Impact of Hematopoietic Cell Transplantation on Myocardial Fibrosis in Young
  Patients with Sickle Cell Disease
date: '2024-05-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38691679/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240502181202&v=2.18.0.post9+e462414
source: Blood
description: Serial cardiovascular magnetic resonance evaluation of children and young
  adults with sickle cell disease (SCD) who underwent hematopoietic cell transplantation
  (HCT) showed that the mean ECV, representing diffuse myocardial fibrosis, decreased
  by 3.4% from the baseline to 12-months post HCT. ...
disable_comments: true
---
Serial cardiovascular magnetic resonance evaluation of children and young adults with sickle cell disease (SCD) who underwent hematopoietic cell transplantation (HCT) showed that the mean ECV, representing diffuse myocardial fibrosis, decreased by 3.4% from the baseline to 12-months post HCT. ...